Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Friday, November 20, 2020

Day-by-Day Blood Pressure Variability Is Associated With Neurological Functional Outcome After Acute Ischemic Stroke

 Of what use is this to survivors? How will anything here get survivors to 100% recovery?

Day-by-Day Blood Pressure Variability Is Associated With Neurological Functional Outcome After Acute Ischemic Stroke

 
Changqiang Yang1, Kai Liu1, Yue Song2, Shenzhen Gong1, Runyu Ye1, Zhipeng Zhang1 and Xiaoping Chen1*
  • 1West China Hospital, Sichuan University, Chengdu, China
  • 2West China Second University Hospital, Sichuan University, Chengdu, China

Background: Increased blood pressure variability (BPV) might be a detrimental factor after acute ischemic stroke. Previous studies on the association between blood pressure variability in the acute ischemic stroke and functional outcome have yielded inconsistent results. We aimed to investigate the impact of day-by-day blood pressure variability within 7 days of onset on functional outcome at 3 months after acute ischemic stroke.

Methods: Total 367 patients hospitalized for ischemic stroke within 48 h of onset were enrolled. The acute stage of ischemic stroke was defined as the time period from symptom onset to 7 days. During this period, blood pressure was measured twice daily (respectively, in the morning during 8:00 a.m.−10:00 a.m., in the afternoon between 15:00 p.m. and 17:00 p.m.). Day-by-day blood pressure variability, including standard deviation (SD) and coefficient variation (CV) were derived and compared to functional outcome. We dichotomized function outcome according to mRS score and unfavorable outcome was defined as mRS ≥3.

Results: The patients with unfavorable outcome had significantly higher systolic BPV (within 7 days of onset) than those with favorable outcome (15.41 ± 4.59 vs. 13.42 ± 3.95 mmHg for SD, P < 0.001; 11.54 ± 3.23 vs. 10.41 ± 2.82 for CV, P = 0.001). Multivariable logistic regression analysis revealed that systolic BPV was significantly and independently associated with the 3-month functional outcome [odds ratio (OR) = 1.15, 95% confidence interval (CI): 1.07–1.22, P < 0.001 for SD; OR = 1.15, 95% CI: 1.06–1.26, P = 0.001 for CV]. In addition, After adjustment for multiple confounding factors, including age, gender, risk factors, stroke features, baseline severity, recanalized therapy, hemorrhagic transformation, pulmonary infection, white blood cell, estimated Glomerular Filtration Rate and mean BP, day-by-day BP variability was significantly correlated with an unfavorable outcome in the top vs. bottom quartile of systolic BPV (OR = 3.33, 95% CI: 1.41–7.85, P = 0.006 for SD; OR = 2.27, 95% CI: 1.04–4.94, P = 0.037 for CV) during 3-month follow-up. Similar trends were also observed for diastolic BPV. More importantly, incorporating SD of systolic BP into the conventional prediction model could significantly increase the AUC for prediction of 3-month unfavorable outcome after acute ischemic stroke (0.84 vs. 0.86; P = 0.0416).

Conclusions: Increased day-by-day blood pressure variability of systolic or diastolic BP in the acute ischemic stroke was associated with higher risk for unfavorable outcome at 3 months independent of blood pressure levels. Combining SD of systolic BP with conventional risk factors could improve the prediction of unfavorable outcome.

Introduction

Hypertension is the most prevalent modifiable risk factor for ischemic stroke and blood pressure reduction is an important goal for stroke risk reduction (1). Optimal blood pressure levels have been well-established for the primary and secondary prevention of ischemic stroke occurrence and recurrence (2). However, the optimal management of blood pressure during the acute stage of ischemic stroke has not been confirmed and remains controversial (3). A series of randomized clinical trials of blood pressure lowering in acute ischemic stroke have been conducted and showed a neutral effect of BP reduction on clinical outcomes (48). Recent studies have suggested that the risk of cardiovascular complications may not only depend on the magnitude of blood pressure elevation but also on the presence of increased blood pressure variability, even to a larger extent than average BP values in populations at high cardiovascular risk (9). Therefore, blood pressure variability may be an important predictor of ischemic stroke risk and outcome.

Available evidence about the effect of BPV on outcome after acute ischemic stroke is scarce. Most studies focus on the association between short-term blood pressure variability (BPV) within first 24–72 h after ischemic stroke onset and functional outcome (1015). Some report that short-term BPV is associated with unfavorable outcome at 3 months after acute ischemic stroke (1214), whereas others do not find any association (10, 11, 15). A recent systemic review and meta-analysis suggests that this short-term blood pressure variability assessed in the acute stage of ischemic stroke is associated with poor long-term functional outcome (16). However, there are limited data regarding the relationship between mid-term blood pressure variability (day-by-day BPV) and outcome in acute ischemic stroke. The aim of the present study is to investigate whether day-by-day blood pressure variability within 7 days of onset is associated with 3-month functional outcome of patients with acute ischemic stroke.

No comments:

Post a Comment